![Michael Wheatcroft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Wheatcroft
Chief Tech/Sci/R&D Officer at
TELIX PHARMACEUTICALS LIMITED
Profile
Michael Wheatcroft currently works at Telix Pharmaceuticals Ltd., as Chief Scientist from 2021.
Dr. Wheatcroft also formerly worked at MedImmune U.K.
Ltd., as Principal and Avipep Pty Ltd., as Research Manager.
Dr. Wheatcroft received his doctorate degree from the University of Cambridge.
Michael Wheatcroft active positions
| Companies | Position | Start |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Chief Tech/Sci/R&D Officer | - |
Former positions of Michael Wheatcroft
| Companies | Position | End |
|---|---|---|
MedImmune U.K. Ltd.
 MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Corporate Officer/Principal | - |
Avipep Pty Ltd.
 Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Corporate Officer/Principal | - |
Training of Michael Wheatcroft
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
2
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedImmune U.K. Ltd.
MedImmune U.K. Ltd. Chemicals: Major DiversifiedProcess Industries Manufactures chemical products | Process Industries |
Avipep Pty Ltd.
Avipep Pty Ltd. Medical SpecialtiesHealth Technology Commercializes protein biopharmaceuticals and in vivo diagnostic products | Health Technology |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Michael Wheatcroft
